News | January 13, 2014

Study Shows Radiotherapy After Mastectomy Does Not Affect Mechanism in AeroForm Expander

airxpanders aeroform tissue expander radiation therapy
January 13, 2014 — AirXpanders Inc., a developer of technology for women who require tissue expansion for breast reconstruction following a mastectomy, announced new data published in The Journal of Radiation Oncology that demonstrates the AeroForm Tissue Expander can withstand radiation levels well above the maximum dose level typically used in post-mastectomy radiation therapy.
 
"Once a woman undergoes a mastectomy, she may still have to undergo radiation therapy. AeroForm offers women a more gradual, patient-controlled option for expansion, and I'm pleased to see that the device is unaffected even by extremely high levels of radiation," said James Rembert, M.D., radiation oncologist. Alta Bates Summit Comprehensive Cancer Center, Berkeley, Calif. "It is further proof that women who require additional radiation can feel confident that the AeroForm will not be impacted, so that they can continue to make progress towards regaining their shape even while continuing to receive treatment."
 
The study determined that the electronics inside the AeroForm expander continued to function properly after exposure to radiation levels up to 75 Gy — well above the maximum dose level (50-60 Gy). Following radiation exposure, 32 tissue expanders were functionally tested, and each successfully established communication with the dosage controller and deliver three CO2 doses according to product specifications.
 
A second, separate poster presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting by Jeffrey Kuo, M.D., University of California, Irvine. He demonstrated that the AeroForm expander did not significantly impede the delivery of radiation doses compared to dosing in breast cancer patients who have intact breasts. Results showed that measured skin doses varied only from -12 to +12 percent and suggested that computed tomography (CT) scans can help optimize dose variation.
 
"This data confirms that AeroForm is not adversely affected by radiation therapy, and there is minimal interference in the delivery of radiotherapy with an AeroForm implant in place," said Scott Dodson, president and CEO, AirXpanders. "As with all tissue expanders, the decision to use radiotherapy in conjunction with a tissue expander is at the discretion of the radiation oncologist and plastic surgeon. We are diligently working towards regulatory approval in Australia and expect to complete U.S. trial enrollment by the end of the year."
 

Related Content

DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
Overlay Init